Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Lung Cancer

  Free Subscription


26.03.2018

1 Ann Thorac Surg
1 Arch Bronconeumol
1 Arch Pathol Lab Med
3 BMC Cancer
2 Carcinogenesis
1 Clin Cancer Res
3 Clin Lung Cancer
1 Clin Nucl Med
1 Eur J Cardiothorac Surg
2 Eur Respir J
2 Int J Radiat Oncol Biol Phys
2 J Cancer Res Clin Oncol
3 J Thorac Cardiovasc Surg
2 Lancet Oncol
1 Mol Carcinog
3 Oncol Rep
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Thorac Surg

  1. GREGORY J, Bennani S, Freche G, Mansuet-Lupo A, et al
    Synchronous Presentation of Pheochromocytoma and Epidermoid Lung Carcinoma.
    Ann Thorac Surg. 2018 Mar 15. pii: S0003-4975(18)30346.
    PubMed     Text format    


    Arch Bronconeumol

  2. PEREZ-MARTINEZ O, Vidal-Garcia I, Montero-Martinez C, Provencio M, et al
    Description and Survival of Stage I and II Lung Cancer Patients.
    Arch Bronconeumol. 2018 Mar 16. pii: S0300-2896(18)30061.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  3. JAIN D, Roy-Chowdhuri S
    Molecular Pathology of Lung Cancer Cytology Specimens: A Concise Review.
    Arch Pathol Lab Med. 2018 Mar 16. doi: 10.5858/arpa.2017-0444.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. FIDLER MJ, Fhied CL, Roder J, Basu S, et al
    The serum-based VeriStrat(R) test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients.
    BMC Cancer. 2018;18:310.
    PubMed     Text format     Abstract available

  5. LYNCH JA, Berse B, Rabb M, Mosquin P, et al
    Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.
    BMC Cancer. 2018;18:306.
    PubMed     Text format     Abstract available

  6. HAKOZAKI T, Okuma Y, Kashima J
    Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case report.
    BMC Cancer. 2018;18:302.
    PubMed     Text format     Abstract available


    Carcinogenesis

  7. RYAN BM
    Lung Cancer Health Disparities.
    Carcinogenesis. 2018 Mar 14. pii: 4935154. doi: 10.1093.
    PubMed     Text format     Abstract available

  8. TORIGOE H, Yamamoto H, Sakaguchi M, Youyi C, et al
    Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.
    Carcinogenesis. 2018 Mar 13. pii: 4931626. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  9. HORN L, Infante JR, Reckamp KL, Blumenshein GR, et al
    Ensartinib (X-396) in ALK-positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study.
    Clin Cancer Res. 2018 Mar 21. pii: 1078-0432.CCR-17-2398.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  10. FARRELL MJ, Yahya JB, Degnin C, Chen Y, et al
    Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Clin Lung Cancer. 2018 Feb 23. pii: S1525-7304(18)30042.
    PubMed     Text format     Abstract available

  11. TAKASHIMA Y, Sakakibara-Konishi J, Hatanaka Y, Hatanaka KC, et al
    Clinicopathologic Features and Immune Microenvironment of Non-Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    Clin Lung Cancer. 2018 Feb 19. pii: S1525-7304(18)30023.
    PubMed     Text format     Abstract available

  12. STONE CJL, Vaid HM, Selvam R, Ashworth A, et al
    Multidisciplinary Clinics in Lung Cancer Care: A Systematic Review.
    Clin Lung Cancer. 2018 Feb 21. pii: S1525-7304(18)30020.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  13. WILSON B, Becker A, Estes T, Keshavamurthy J, et al
    Adrenal Hemangioma Definite Diagnosis on CT, MRI, and FDG PET in a Patient With Primary Lung Cancer.
    Clin Nucl Med. 2018 Mar 20. doi: 10.1097/RLU.0000000000002069.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  14. DZIEDZIC R, Marjanski T, Binczyk F, Polanska J, et al
    Favourable outcomes in patients with early-stage non-small-cell lung cancer operated on by video-assisted thoracoscopic surgery: a propensity score-matched analysis.
    Eur J Cardiothorac Surg. 2018 Mar 14. pii: 4934946. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur Respir J

  15. ZUGAZAGOITIA J, Biosca M, Olivera J, Eugenia Olmedo M, et al
    Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small-cell lung cancer.
    Eur Respir J. 2018 Mar 21. pii: 13993003.02431-2017.
    PubMed     Text format    

  16. LOUBIERE S, Drezet A, Beau-Faller M, Moro-Sibilot D, et al
    Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  17. VYFHUIS MAL, Burrows WM, Bhooshan N, Suntharalingam M, et al
    Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Feb 13. pii: S0360-3016(18)30250.
    PubMed     Text format     Abstract available

  18. LIU C, Schild SE, Chang JY, Liao Z, et al
    Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Feb 14. pii: S0360-3016(18)30256.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  19. LI J, You W, Zheng D, Yan B, et al
    A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid component.
    J Cancer Res Clin Oncol. 2018;144:725-734.
    PubMed     Text format     Abstract available

  20. YUAN Y, Ma G, Zhang Y, Chen H, et al
    Presence of micropapillary and solid patterns are associated with nodal upstaging and unfavorable prognosis among patient with cT1N0M0 lung adenocarcinoma: a large-scale analysis.
    J Cancer Res Clin Oncol. 2018;144:743-749.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  21. CHENG X, Zheng D, Li Y, Li H, et al
    Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Feb 13. pii: S0022-5223(18)30362.
    PubMed     Text format     Abstract available

  22. MAO Q, Xia W, Dong G, Chen S, et al
    A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
    J Thorac Cardiovasc Surg. 2018;155:1784-1792.
    PubMed     Text format     Abstract available

  23. SEPESI B, Ye Y, Mitchell KG, Zhang L, et al
    Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Feb 15. pii: S0022-5223(18)30372.
    PubMed     Text format     Abstract available


    Lancet Oncol

  24. LIN JJ, Gainor JF
    ATLANTIC: a sea change in immunotherapy for oncogene-driven lung cancer?
    Lancet Oncol. 2018 Mar 12. pii: S1470-2045(18)30160.
    PubMed     Text format    

  25. GARASSINO MC, Cho BC, Kim JH, Mazieres J, et al
    Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
    Lancet Oncol. 2018 Mar 12. pii: S1470-2045(18)30144.
    PubMed     Text format     Abstract available


    Mol Carcinog

  26. YANG Y, Sun Y, Wu Y, Tang D, et al
    Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/beta-catenin signaling in non-small-cell lung cancer.
    Mol Carcinog. 2018 Mar 22. doi: 10.1002/mc.22805.
    PubMed     Text format     Abstract available


    Oncol Rep

  27. LI Y, Wei Y, Yuan W, Huang Q, et al
    DNA damage induced by human CD40 ligand mutant promotes senescence and induces demethylation of GATA4 in lung cancer.
    Oncol Rep. 2018;39:2071-2080.
    PubMed     Text format     Abstract available

  28. XU S, Yang F, Liu R, Li X, et al
    Serum microRNA-139-5p is downregulated in lung cancer patients with lytic bone metastasis.
    Oncol Rep. 2018;39:2376-2384.
    PubMed     Text format     Abstract available

  29. PAN Y, Wang H, Ma D, Ji Z, et al
    miR24 may be a negative regulator of menin in lung cancer.
    Oncol Rep. 2018;39:2342-2350.
    PubMed     Text format     Abstract available


    PLoS One

  30. BUHL IK, Santoni-Rugiu E, Ravn J, Hansen A, et al
    Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
    PLoS One. 2018;13:e0194609.
    PubMed     Text format     Abstract available

  31. DEHUA Z, Mingming C, Jisheng W
    Meta-analysis of gemcitabine in brief versus prolonged low-dose infusion for advanced non-small cell lung cancer.
    PLoS One. 2018;13:e0193814.
    PubMed     Text format     Abstract available

  32. CHANG WY, Wu YL, Su PL, Yang SC, et al
    The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.
    PLoS One. 2018;13:e0192161.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: